Content about GlaxoSmithKline

PARSIPPANY, N.J. —GlaxoSmithKline in April announced the launch of its new Nicorette Mini Lozenge, a smaller smoking cessation lozenge that dissolves three times faster than stop-smoking lozenges currently on the market. The lozenges will be line-priced with existing smoking cessation products and will be sold as three small vials each containing 27 lozenges.

PITTSBURGH In light of a new survey that shows families may not be properly addressing their oral healthcare needs, GlaxoSmithKline Consumer Healthcare is launching a first-of-its-kind online resource for people seeking oral health education and personalized oral care plans for each family member.

By visiting WealthOfOralHealth.com and completing a brief survey, consumers can immediately receive a customized plan for each family member, addressing important conditions ranging from bad breath, cavities, acid erosion and sensitive teeth.

RESEARCH TRIANGLE PARK, N.C. GlaxoSmithKline is offering its vaccines free of charge to low-income adults, the British drug maker announced Monday.

The GSK Vaccines Access Program offers adult vaccines for diseases such as hepatitis, tetanus and human papillomavirus for adults ages 19 years and older who lack health insurance coverage for vaccines.